News & Analysis

Word speak louder than actions! – Tweets move the markets whilst reopening does not

Andrew Saks, Monday, 17 May 2021

No movements in the GBP today despite reopening in the UK, whilst FTSE 100 is hyperactive this morning

Read more

News & Analysis

Which way will Boris Johnson turn the key?

Andrew Saks, Friday, 14 May 2021

Pharma stocks rocket, pound stagnates. Is Boris Johnson’s possible lockdown extension a blow for the proposed boom?

Read more

News & Analysis

Post-IPO Alphawave tanks at a time of massive highs in London and New York. What’s going on?

Andrew Saks, Friday, 14 May 2021

Traders and investors are looking at New York and London as clamor around inflation came to nothing, yet stock on FTSE 100 and Dow Jones are extremely high. Perhaps London isn’t so favorable to tech stocks.

Read more

News & Analysis

Inflation is normal. It's the investor revolts in tradable assets that show real people power

Andrew Saks, Thursday, 13 May 2021

Traders and shareholders are now waging war against boards of companies in which they own stock over even relatively small pay deals for bosses. It is the age of the trader being in control

Read more

News & Analysis

Shareholder meltdown! AstraZeneca poised for volatility as pay row erupts

Andrew Saks, Wednesday, 12 May 2021

All eyes are on AstraZeneca stock as a shareholder row erupts in the City

Read more

News & Analysis

There's no such thing as evergreen: The world turns its back on tech stocks

Andrew Saks, Wednesday, 12 May 2021

The rebirth of the ETF has emerged in America, whilst the fickle world of trading turns its back on big tech stock, bringing the NASDAQ, Dow Jones and S&P down whilst listed funds rocket

Read more

Ready to get started?

Open live account Open demo account